Segall Bryant & Hamill’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Sell
95,068
-9,233
-9% -$390K 0.04% 392
2026
Q1
$5.77M Sell
104,301
-16,328
-14% -$777K 0.08% 290
2025
Q4
$4.51M Sell
120,629
-1,269
-1% -$51.5K 0.06% 329
2025
Q3
$4.93M Sell
121,898
-28,247
-19% -$933K 0.07% 312
2025
Q2
$3.83M Sell
150,145
-14,160
-9% -$309K 0.05% 347
2025
Q1
$3.51M Sell
164,305
-3,485
-2% -$77.9K 0.05% 361
2024
Q4
$3.52M Sell
167,790
-6,779
-4% -$157K 0.05% 380
2024
Q3
$3.93M Buy
174,569
+2,971
+2% +$57.4K 0.05% 361
2024
Q2
$2.88M Buy
+171,598
New +$2.76M 0.05% 348
2020
Q3
Sell
-23,296
Closed -$612K 761
2020
Q2
$612K Sell
23,296
-54,840
-70% -$1.36M 0.01% 547
2020
Q1
$1.89M Buy
78,136
+21,733
+39% +$531K 0.04% 342
2019
Q4
$1.4M Sell
56,403
-103,269
-65% -$2.4M 0.02% 459
2019
Q3
$3.41M Sell
159,672
-333,492
-68% -$9.14M 0.05% 324
2019
Q2
$15.7M Buy
493,164
+2,797
+0.6% +$87.7K 0.24% 115
2019
Q1
$16.2M Sell
490,367
-28,601
-6% -$890K 0.25% 111
2018
Q4
$16.7M Buy
518,968
+61,134
+13% +$2.31M 0.29% 96
2018
Q3
$19.6M Sell
457,834
-13,909
-3% -$657K 0.29% 90
2018
Q2
$21.7M Buy
+471,743
New +$20.9M 0.33% 76

Other funds holding PAHC

Segall Bryant & Hamill's PAHC Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Phibro Animal Health (PAHC) stake by 8.9% in Q2 2026, selling an estimated $390K and leaving 95,068 shares worth $2.99M. The position accounts for 0.04% of the portfolio, ranked #392.

Segall Bryant & Hamill first reported a position in PAHC in Q2 2018 and has held it in 18 quarters since. The position peaked at $21.7M in Q2 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Segall Bryant & Hamill held 95,068 shares of Phibro Animal Health worth $2.99M as of Q2 2026.
  • Segall Bryant & Hamill sold 9,233 Phibro Animal Health shares in Q2 2026, an estimated $390K.
  • Phibro Animal Health made up 0.04% of Segall Bryant & Hamill's portfolio in Q2 2026, its #392 holding.
  • Segall Bryant & Hamill first reported a position in Phibro Animal Health in Q2 2018 and has held it in 18 quarters since.
  • Segall Bryant & Hamill's Phibro Animal Health position peaked at $21.7M in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.